Ładowanie...
Zródło
Erdogan A., Rao S.S.C., Small Intestinal Fungal Overgrowth, „Current Gastroenterology Reports” 2015, 17(4), 16.
Jacobs C. et al., Dysmotility and proton pump inhibitor use are independent risk factors for small intestinal bacterial and/or fungal overgrowth, „Alimentary Pharmacology & Therapeutics” 2013, 37(11), 1103–1111.
Otašević S. et al., The dietary modification and treatment of intestinal Candida overgrowth – a pilot study, „Journal de Mycologie Médicale” 2018, 28(4), 623–627.
Pimentel M. et al., ACG Clinical Guideline: Small Intestinal Bacterial Overgrowth, „The American Journal of Gastroenterology” 2020, 115(2), 165–178.
Wang Z.K. et al., Review article: fungal microbiota and digestive diseases, „Alimentary Pharmacology and Therapeutics” 2014, 39(8), 751–766.
Erdogan A., Rao S.S.C., Small Intestinal Fungal Overgrowth, „Current Gastroenterology Reports” 2015, 17(4), 16.
Jacobs C. et al., Dysmotility and proton pump inhibitor use are independent risk factors for small intestinal bacterial and/or fungal overgrowth, „Alimentary Pharmacology & Therapeutics” 2013, 37(11), 1103–1111.
Otašević S. et al., The dietary modification and treatment of intestinal Candida overgrowth – a pilot study, „Journal de Mycologie Médicale” 2018, 28(4), 623–627.
Pimentel M. et al., ACG Clinical Guideline: Small Intestinal Bacterial Overgrowth, „The American Journal of Gastroenterology” 2020, 115(2), 165–178.
Wang Z.K. et al., Review article: fungal microbiota and digestive diseases, „Alimentary Pharmacology and Therapeutics” 2014, 39(8), 751–766.